DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

1-10%: 

Dizziness 

Hyperglycemia 

Hypertriglyceridemia 

Rhinitis 

Sinusitis 

Back pain 

Bronchitis 

Diarrhea 

Headache 

Fatigue 

Inflicted injury 

Flulike symptoms 

Pharyngitis 

Respiratory tract infection 

Frequency undefined: 

Anaphylactic reaction 

Angioedema 

Hyperlipidemia 

Gastroenteritis 

Facial edema 

Hyperkalemia 

Tachycardia 

Rhabdomyolysis 

Hypercholesterolemia 

Olmesartan is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients. 

Pregnancy consideration:  

Not indicated for usage in pregnant women 

Breastfeeding warnings:  

The drug excretion in breastmilk is unknown  

Pregnancy category: 

• Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester. 
• Category B: No evidence shows the risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women.    
• Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a human product; Pregnant women must take care of the potential risks. 
• Category D: There is adequate data available with evidence of human fetal risk from various platforms. However, despite potential dangers may be used only in emergency cases for potential benefits. 
• Category X: Drugs listed in this category outweigh the risks over the benefits. The drug is not for pregnant women. 
• Category N: No data is available for the drug under this category. 

Patient information leaflet 

Generic Name:  olmesartan 

Pronounced: olme-sar-tan 

Why do we use olmesartan? 

Olmesartan treats hypertension.